BMO Capital Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform, 'Current Valuation Skews Risk/Reward to Upside'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. GLOB
2. AMAT
3. RDDT
4. ELUT
5. CV
6. YSS
7. SMSI
8. SNDK
9. ADYEN:NA
10. XYL

Go back to BMO Capital Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform, 'Current Valuation Skews Risk/Reward to Upside'
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 68.53 --0 (-0%)
Previous Close $68.53    52 Week High $108.96 
Open $68.53    52 Week Low $62.12 
Day High $68.53    P/E N/A 
Day Low $68.53    EPS $-1.27 
Volume 637